
ConclusionsĬurcuminoids with diferuloyl(4-hydroxy-3-methoxycinnamoyl) moiety with mono carbonyl exhibiting potential cytotoxic properties. Structure–activity relationships revealed that the mono-carbonyl with 2,5-dimethoxy substituted curcuminoids could be an essential for the future drugs against cancer diseases. Additionally, we are going to report the first time spectral data of (2 E,6 E)-2,6-bis(2-methoxybenzylidene)cyclohexanone ( 1). The structure of compound 4 was confirmed by using the single X-ray crystallography. All the curcucminoids were characterized with the detailed 1H NMR, IR, UV–Vis, and mass spectroscopic techniques. Among the cyclohexanone series, the compound 4 exhibited (IC 50 = 11.04 ± 2.80, 6.50 ± 01.80, 8.70 ± 3.10 and 2.30 ± 1.60 µg/mL) potential cytotoxicity against four proposed cancer cell lines, respectively.

Bruker apex ii duo ccd diffractometer series#
Among them, acetone series 11– 17 were found to be more selective and potential cytotoxic agents. These curcuminoids 1– 24 were screened against HeLa, K562, MCF-7 (an estrogen-dependent) and MDA-MB-231 (an estrogen-independent) cancer cell lines. All the curcuminoids were synthesized by the acid or base catalyzed Claisen Schmidt condenstion reactions, in which β-diketone moiety of curcumin was modified with mono-ketone. Twenty-four curcumin derivatives have synthesized, which comprises cyclohexanone 1– 10, acetone 11– 17 and cyclopentanone 18– 24 series. However, in vivo administration exhibited limited applications in cancer therapies. Ziegler for more information on pricing.Curcumin is one of the leading compound extracted from the dry powder of Curcuma longa (Zingiberaceae family), which possess several pharmacological properties. ** Academic institutions should contact Dr. Single Crystal Data Collection & Structure University of Akron Departments In such cases the name of the responsible crystallographer will be included. Policy: There will be a policy of co-authorship in all publications that present collected and solved structures. Users who publish papers including data collected on the Bruker APEX II Duo system should include the following statement: We would like to acknowledge the National ScienceFoundation (CHE-0840446) for funds used to purchase the Bruker APEX II Duo X-ray diffractometer used in this research. Meetings and Consultations by Appointments onlyĪcknowledgments: Users who publish papers including data collected on the Bruker SMART APEX I system should include the following statement: We would like to acknowledge the National ScienceFoundation (CHE-0116041) and the Ohio Board of Regents for funds used to purchase the Bruker-Nonius Apex CCD X-ray diffractometer used in this research.

Recrystallization for optimal data analysis
